Prospects for a MERS-CoV spike vaccine

Y Zhou, S Jiang, L Du - Expert review of vaccines, 2018 - Taylor & Francis
Introduction: Six years have passed since Middle East respiratory syndrome (MERS)
coronavirus (MERS-CoV), a newly emerging infectious virus, was first reported in 2012 …
被引用次数：151 相关文章

Prospects for a MERS-CoV spike vaccine

Y Zhou, S Jiang, L Du - Expert review of vaccines, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction Six years have passed since Middle East respiratory syndrome (MERS)
coronavirus (MERS-CoV), a newly emerging infectious virus, was first reported in 2012 …
[HTML] nih.gov

[HTML][HTML] Prospects for a MERS-CoV spike vaccine

Y Zhou, S Jiang, L Du - Expert review of vaccines, 2018 - ncbi.nlm.nih.gov
Introduction: Six years have passed since Middle East respiratory syndrome (MERS)
coronavirus (MERS-CoV), a newly emerging infectious virus, was first reported in 2012 …

[引用][C] Prospects for a MERS-CoV spike vaccine

Y Zhou, S Jiang, L Du - Expert Review of Vaccines, 2018 - cir.nii.ac.jp
Prospects for a MERS-CoV spike vaccine | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …

Prospects for a MERS-CoV spike vaccine.

Y Zhou, S Jiang, L Du - Expert Review of Vaccines, 2018 - europepmc.org
Introduction: Six years have passed since Middle East respiratory syndrome (MERS)
coronavirus (MERS-CoV), a newly emerging infectious virus, was first reported in 2012 …

Prospects for a MERS-CoV spike vaccine.

Y Zhou, S Jiang, L Du - Expert Review of Vaccines, 2018 - europepmc.org
Six years have passed since Middle East respiratory syndrome (MERS) coronavirus (MERS-
CoV), a newly emerging infectious virus, was first reported in 2012. Although MERS-CoV …